IHP公布最新制定的淋巴瘤治疗指南

 
一组癌症和影像学专家组成的国际小组，制定了一项评估淋巴瘤治疗反应的标准指南。该指南将为全球范围的临床医生提供统一标准，用以比较和解释淋巴瘤治疗的临床试验，从而推动新治疗措施的开发。

该新指南是由国际统一标准化项目(IHP)研发的，是根据1999年由包括临床医生、放射科医生和病理学家组成的国际工作小组(IWG)制定的非何杰金淋巴瘤治疗反应评估标准而制定的。

PET是一种非侵入性影像技术，该技术利用了注射的化学示踪剂发射出的放射活性。PET使用的放射示踪剂最典型的是氟脱氧葡萄糖(FDG)，这是葡萄糖的放射性标记形式，该物质主要被肿瘤而不是正常组织所利用。

Guidelines Add PET for Evaluating Lymphoma Treatment
 
An international team of cancer and imaging specialists has developed standardized guidelines for assessing lymphoma response to treatment. The guidelines will provide clinicians worldwide with uniform criteria to compare and interpret clinical trials of lymphoma treatments and should facilitate the development of new therapies.

The new guidelines, developed by the International Harmonization Project (IHP), build on criteria for treatment response assessment of non-Hodgkin’s lymphoma published in 1999 by an international working group (IWG) of clinicians, radiologists, and pathologists.

PET is a non-invasive imaging technique that uses radioactivity emitted from injected tracer chemicals to measure and image biologic activity. The most typically used PET radiotracer is fluorodeoxyglucose (FDG), a radiolabeled form of glucose, which is consumed more avidly by tumors than by healthy tissue.